Effects of burosumab on macrophage polarization and TRPV1 expression in children with XLH
{{output}}
Purpose: X-linked hypophosphatemia (XLH) is a rare genetic disorder caused by PHEX mutations, leading to hypophosphatemia and impaired bone mineralization. Burosumab, a monoclonal antibody targeting FGF23, improves phosphate leve... ...
